These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19679874)

  • 21. HMGB1 and RAGE in inflammation and cancer.
    Sims GP; Rowe DC; Rietdijk ST; Herbst R; Coyle AJ
    Annu Rev Immunol; 2010; 28():367-88. PubMed ID: 20192808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between RAGE and TLR4 Regulates HMGB1-Induced Inflammation by Promoting Cell Surface Expression of RAGE and TLR4.
    Zhong H; Li X; Zhou S; Jiang P; Liu X; Ouyang M; Nie Y; Chen X; Zhang L; Liu Y; Tao T; Tang J
    J Immunol; 2020 Aug; 205(3):767-775. PubMed ID: 32580932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection.
    Yaghouti N; Boostani R; Mohamamdi A; Poursina Z; Rezaee SA; Vakili V; Valizadeh N; Shams A; Rafatpanah H
    Viral Immunol; 2019 Mar; 32(2):89-94. PubMed ID: 30585773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
    Basta G
    Atherosclerosis; 2008 Jan; 196(1):9-21. PubMed ID: 17826783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation.
    Hiraku Y; Guo F; Ma N; Yamada T; Wang S; Kawanishi S; Murata M
    Part Fibre Toxicol; 2016 Mar; 13():16. PubMed ID: 27026438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
    Prasad K
    Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review.
    De Martinis M; Ginaldi L; Sirufo MM; Pioggia G; Calapai G; Gangemi S; Mannucci C
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32204562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
    Yu SL; Wong CK; Szeto CC; Li EK; Cai Z; Tam LS
    Lupus; 2015 Jun; 24(7):675-86. PubMed ID: 25411258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative impairment of cognitive function in old mice: a possible role for neuroinflammation mediated by HMGB1, S100B, and RAGE.
    Li RL; Zhang ZZ; Peng M; Wu Y; Zhang JJ; Wang CY; Wang YL
    J Surg Res; 2013 Dec; 185(2):815-24. PubMed ID: 23899512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High mobility group box-1 induces pro-inflammatory signaling in human nucleus pulposus cells via toll-like receptor 4-dependent pathway.
    Shah BS; Burt KG; Jacobsen T; Fernandes TD; Alipui DO; Weber KT; Levine M; Chavan SS; Yang H; Tracey KJ; Chahine NO
    J Orthop Res; 2019 Jan; 37(1):220-231. PubMed ID: 30273982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary Tuberculosis.
    Lui G; Wong CK; Ip M; Chu YJ; Yung IM; Cheung CS; Zheng L; Lam JS; Wong KT; Sin WW; Choi KW; Lee N
    PLoS One; 2016; 11(7):e0159132. PubMed ID: 27434276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HMGB1 receptor RAGE mediates ischemic brain damage.
    Muhammad S; Barakat W; Stoyanov S; Murikinati S; Yang H; Tracey KJ; Bendszus M; Rossetti G; Nawroth PP; Bierhaus A; Schwaninger M
    J Neurosci; 2008 Nov; 28(46):12023-12031. PubMed ID: 19005067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMGB1-RAGE signaling pathway in pPROM.
    Yan H; Zhu L; Zhang Z; Li H; Li P; Wang Y; Leng M
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):211-216. PubMed ID: 29673663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury.
    Lee S; Piao C; Kim G; Kim JY; Choi E; Lee M
    Eur J Pharm Sci; 2018 Mar; 114():275-284. PubMed ID: 29292016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
    Basta G; Del Turco S; Navarra T; Lee WM;
    Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for activation of Toll-like receptor and receptor for advanced glycation end products in preterm birth.
    Noguchi T; Sado T; Naruse K; Shigetomi H; Onogi A; Haruta S; Kawaguchi R; Nagai A; Tanase Y; Yoshida S; Kitanaka T; Oi H; Kobayashi H
    Mediators Inflamm; 2010; 2010():490406. PubMed ID: 21127710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome.
    Ingels C; Derese I; Wouters PJ; Van den Berghe G; Vanhorebeek I
    Shock; 2015 Feb; 43(2):109-16. PubMed ID: 25394242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.